These success, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 assist the strategy of focusing on ACKR3 as a unique solution to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar Issues.We independently investigate, assessment, and